Abstract Library

#4597 FIT-NETs: Assessing the effects of an exercise programme on the physical and emotional well-being of patients with advanced G1-2 NETs of GEP or unknown origin

Introduction: Physical activity programs in solid tumours have shown to improve symptom control and even survival, but their impact on NENs remains unexplored. Advanced disease, systemic therapy, and hormonal secretion in these tumours often lead to muscle wasting and sarcopenia.

Conference:

Presenting Author: Anton-Pascual B

Authors: Anton-Pascual B, Rodriguez-Gomez J, de Cima A, Herrero-Llorente A, Modrego A,

Keywords: FIT-NET, physical exercise program, Quadriceps, MEP & MIP, QoL,

#4511 Sequencing chemotherapy and radiotherapy leading to complete remission in a patient with highly aggressive, advanced neuroendocrine cancer of unknown origin

Introduction: Neuroendocrine neoplasms arise from endocrine cells throughout the body, primary tumour may be localised in various organs. Neuroendocrine carcinoma (NEC) is very aggressive form of these tumours with survival limited usually to a few months despite oncological treatment.

Conference:

Presenting Author: Hajac �

Authors: Szymańska P, Hajac L, Chowaniec Z, Marzec R, Sokołowski M,

Keywords: neuroendocrine cancer, radiotherapy, oligometastatic disease,

#4295 Are patients on somatostatin analogue therapy receiving high quality holistic cancer nursing care?

Introduction: SSA is indicated for the treatment of G1 and some G2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs) of midgut, pancreatic or unknown origin in adult patients with unresectable locally advanced or metastatic disease. As these types of cancer have much lower proliferation rates than common cancers, they are not exclusively considered cancer. It is hypothesised these patients may subsequently receive sub-standard cancer care. Furthermore, patients who are diagnosed with metastatic G3 neuroendocrine cancers will require systemic treatment with significant side effect profiles impacting negatively on quality of life.

Conference:

Presenting Author:

Authors: Wotherspoon I,

Keywords: Cancer nursing,

#4080 Synchronous case of advanced gastric Her-2 + adenocarcinoma and metastatic neuroendocrine neoplasm of unknown origin – A MiNEN case?

Introduction: Gastric adenocarcinoma case treated with capecitabine and trastuzumab. After surgery, a G2 neuroendocrine tumor was found.

Conference:

Presenting Author:

Authors: Jimenez Gordo A, Gomez Raposo C, Garcia-Sancho Tellez L, Salinas Moreno S, Madrid Vallenilla A,

Keywords: MiNEN, clonal selection, citostatic treatment,

#3794 Impact of gender on treatment decisions and outcome in patients with neuroendocrine neoplasms

Introduction: Gender differences affect the treatment of several diseases in both male and female patients. However, the influence of gender on treatment decisions and outcome in neuroendocrine neoplasms (NENs) has scarcely been investigated.

Conference:

Presenting Author: Beck J

Authors: Beck J, Siebenhüner A, Wild D, Christ E, Refardt J,

Keywords: gender bias, registry, survival analysis,